Family · Pharmaceutical analytical standards
Amineptine
An atypical tricyclic antidepressant developed in France in the 1960s and introduced in 1978 for severe depression; unlike other tricyclics it acts mainly on dopamine. Its French authorisation was suspended in 1999. This family brings together the active ingredient and other impurities.
Did you know?In animal studies it promotes wakefulness, so much so that it has been suggested as a possible treatment for narcolepsy; its side chain ends in a seven-carbon acid.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
